All News

Antiviral treatments play a crucial role in the survival of patients with either hepatitis B or C and liver cancer, but researchers have found that antiviral therapy is “severely underutilized” even among patients who undergo curative surgery.

Treatment with Opdivo and chemotherapy improved survival in patients with gastrointestinal cancers, compared with chemotherapy alone, according to a phase 3 trial.

The FDA amended its approval for Balversa for the treatment of patients with locally advanced or metastatic bladder cancer.

As I reflect upon the past, I wonder: Was I just lucky to have turned my health around after fighting and healing from stage 4 bone cancer?

From Broadway actor Jeff Gorti opening up about his childhood cancer experience to Brian Barczyk of The Reptarium dying, here’s what’s happening in the oncology space this week.

A 45-minute cancer procedure deemed me to be "cancer free," but it did not assuage all my anxieties.

Patients recently treated for cancer who required hospitalization for COVID-19 were at risk for venous thromboembolisms (VTEs), recent research has found, with investigators determining that patients who experience a thromboembolic event (TEE) are at a 20% to 25% risk of death.

Patients with advanced gastric cancers tended to have better survival outcomes when given Opdivo plus chemotherapy, compared to those who were given chemotherapy alone.

When a friend recently asked if I’d ever thought cancer might kill me, I had to think back and examine myself.

Certain tumor characteristics were predictive of which patients with lymphoma may have better outcomes with the CAR-T cell therapy, Yescarta.

BTK degrader NX-5948 has been granted Fast Track designation by the FDA to treat some adults with relapsed or refractory chronic lymphocytic leukemia or relapsed or refractory small lymphocytic lymphoma.

Some with metastatic cancers receiving end-of-life-initiated immunotherapy may have a decreased risk of mortality when treated at a high-volume facility, research found.

The Food and Drug Administration (FDA) has recently approved Keytruda (pembrolizumab) plus chemoradiotherapy for the treatment of patients with stages 3 to 4A cervical cancer.

Whenever I experience a new ache or patch of itchy skin, I immediately think it's a health issue — or a recurrence.

Cancer survivors may face different mental and physical quality of life depending on their socioeconomic factors and age, according to a recent study.

The Lymphedema Treatment Act went into effect on Jan. 1, making prescribed lymphedema compression garments approved by Medicare Part B.

Endocrine therapy, particularly when administered in combination with Verzenio (abemaciclib), is effective when compared with chemotherapy among patients with metastatic breast cancer who experienced disease progression on Ibrance (palbociclib), according to recently published research.

Rates of early mortality from NSCLC decreased in states with Medicaid expansion, according to recent research.

Recently, I have been focusing on the concept of Mattering, and it has boosted my mental health.

Financial burdens from medical costs negatively affect quality of life in patients who have received stem cell transplants, recent research showed.

From Tom Green to Deadpool, humor-based messaging has long been utilized for testicular cancer. Researchers aren’t sure how effective that strategy is.

The novel drug, IDP-023, is being investigated in patients with relapsed or refractory non-Hodgkin lymphoma or multiple myeloma.

Although approximately one-third of patients were found to bypass their nearest hospital for breast cancer surgery, the decision to go further occurred more frequently in certain patient populations.

As a survivor of colorectal cancer, I expect my scan to say that I’m 99% cancer-free, but it’s the 1% that worries me.

Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more.

Patients with melanoma play a vital role in their own post-surgical care, as one expert from Dana-Farber Cancer Institute explained to CURE®.

When I told people I have follicular lymphoma, the first reaction I got is "At least you got a good cancer.”

The FDA granted a Fast Track Designation to RC88, a novel antibody-drug conjugate, to treat patients with platinum-resistant gynecologic cancers.

Being a self-advocate also means self-care.

Recent research determined that two specific biomarkers may help predict and protect survivors of childhood cancer from heart risks, such as cardiomyopathy.